161 related articles for article (PubMed ID: 2457112)
21. Rabies subunit vaccines.
Wunner WH; Dietzschold B; Curtis PJ; Wiktor TJ
J Gen Virol; 1983 Aug; 64 (Pt 8)():1649-56. PubMed ID: 6348210
[No Abstract] [Full Text] [Related]
22. Immunological relationships between rabies virus and rabies-related viruses studied with monoclonal antibodies to Mokola virus.
Vincent J; Bussereau F; Sureau P
Ann Inst Pasteur Virol; 1988; 139(2):157-73. PubMed ID: 3207504
[TBL] [Abstract][Full Text] [Related]
23. Induction of antigen-specific antibody response in human peripheral blood lymphocytes in vitro by a dog kidney cell vaccine against rabies virus (DKCV).
Uytdehaag FG; Osterhaus AD; Loggen HG; Bakker RH; van Asten JA; Kreeftenberg JG; van der Marel P; van Steenis B
J Immunol; 1983 Sep; 131(3):1234-9. PubMed ID: 6193180
[TBL] [Abstract][Full Text] [Related]
24. Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene.
Wiktor TJ; Macfarlan RI; Reagan KJ; Dietzschold B; Curtis PJ; Wunner WH; Kieny MP; Lathe R; Lecocq JP; Mackett M
Proc Natl Acad Sci U S A; 1984 Nov; 81(22):7194-8. PubMed ID: 6095272
[TBL] [Abstract][Full Text] [Related]
25. [Antigenic relations of the rabies group viruses studied in the blast transformation and immunofluorescence tests].
Vagabov RM; Barinskiĭ IF; Shubladze AK
Vopr Virusol; 1979; (3):293-7. PubMed ID: 380163
[TBL] [Abstract][Full Text] [Related]
26. Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses.
Evans JS; Selden D; Wu G; Wright E; Horton DL; Fooks AR; Banyard AC
J Gen Virol; 2018 Feb; 99(2):169-180. PubMed ID: 29300155
[TBL] [Abstract][Full Text] [Related]
27. Human monoclonal antibodies specific for the rabies virus glycoprotein and N protein.
Lafon M; Edelman L; Bouvet JP; Lafage M; Montchâtre E
J Gen Virol; 1990 Aug; 71 ( Pt 8)():1689-96. PubMed ID: 2391499
[TBL] [Abstract][Full Text] [Related]
28. Cross-protection of mice against a global spectrum of rabies virus variants.
Lodmell DL; Smith JS; Esposito JJ; Ewalt LC
J Virol; 1995 Aug; 69(8):4957-62. PubMed ID: 7609065
[TBL] [Abstract][Full Text] [Related]
29. Nucleocapsid specific T and B cell responses in humans after rabies vaccination.
Herzog M; Lafage M; Montaño-Hirose JA; Fritzell C; Scott-Algara D; Lafon M
Virus Res; 1992 Jun; 24(1):77-89. PubMed ID: 1626425
[TBL] [Abstract][Full Text] [Related]
30. A novel rabies virus lipopeptide provides a better protection by improving the magnitude of DCs activation and T cell responses.
Liu R; Wang J; Yang Y; Khan I; Dong Y; Zhu N
Virus Res; 2016 Aug; 221():66-73. PubMed ID: 27182006
[TBL] [Abstract][Full Text] [Related]
31. Human anti-idiotypic T lymphocyte clones are activated by autologous anti-rabies virus antibodies presented in association with HLA-DQ molecules.
UytdeHaag F; Claassen I; Bunschoten H; Loggen H; Ottenhoff T; Teeuwsen V; Osterhaus A
J Mol Cell Immunol; 1987; 3(3):145-55. PubMed ID: 2908179
[TBL] [Abstract][Full Text] [Related]
32. DNA-based immunisation against rabies and rabies-related viruses: towards multivalent vaccines.
Perrin P; Jacob Y; Desmézières E; Tordo N
Dev Biol (Basel); 2000; 104():151-7. PubMed ID: 11713814
[TBL] [Abstract][Full Text] [Related]
33. Antigenic variants of rabies virus.
Wiktor TJ; Koprowski H
J Exp Med; 1980 Jul; 152(1):99-112. PubMed ID: 6156982
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-2 production in vitro: a new approach to the study of rabies vaccine immunogenicity as appraised by testing different glycoprotein presentations.
Perrin P; Joffret ML; Oth D; Leclerc C; Sureau P; Thibodeau L
Vaccine; 1988 Aug; 6(4):331-8. PubMed ID: 2461004
[TBL] [Abstract][Full Text] [Related]
35. Detection of rabies virus antibodies in fruit bats (Eidolon helvum) from Nigeria.
Aghomo HO; Ako-Nai AK; Oduye OO; Tomori O; Rupprecht CE
J Wildl Dis; 1990 Apr; 26(2):258-61. PubMed ID: 2187101
[TBL] [Abstract][Full Text] [Related]
36. Vaccination challenge studies with variants of street rabies virus isolated in Nigeria.
Okoh AE; Umoh JU; Ezeokoli CD; Addo PB
Vaccine; 1988 Feb; 6(1):19-24. PubMed ID: 3354253
[TBL] [Abstract][Full Text] [Related]
37. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine.
Yusibov V; Hooper DC; Spitsin SV; Fleysh N; Kean RB; Mikheeva T; Deka D; Karasev A; Cox S; Randall J; Koprowski H
Vaccine; 2002 Aug; 20(25-26):3155-64. PubMed ID: 12163267
[TBL] [Abstract][Full Text] [Related]
38. Structure and expression in baculovirus of the Mokola virus glycoprotein: an efficient recombinant vaccine.
Tordo N; Bourhy H; Sather S; Ollo R
Virology; 1993 May; 194(1):59-69. PubMed ID: 8480429
[TBL] [Abstract][Full Text] [Related]
39. [Antigenic determination of human anti-rabies vaccine against viral street strains common in the wild animal population in Poland].
Seroka D
Med Dosw Mikrobiol; 1994; 46(4):331-47. PubMed ID: 7541494
[TBL] [Abstract][Full Text] [Related]
40. Effect of strain differences on the potency testing of rabies vaccines in mice.
Blancou J; Aubert MF; Cain E; Selve M; Thraenhart O; Bruckner L
J Biol Stand; 1989 Jul; 17(3):259-66. PubMed ID: 2793877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
